Re-establishing peripheral tolerance in the absence of CTLA-4: complementation by wild-type T cells points to an indirect role for CTLA-4 - PubMed (original) (raw)
Re-establishing peripheral tolerance in the absence of CTLA-4: complementation by wild-type T cells points to an indirect role for CTLA-4
Elizabeth A Tivol et al. J Immunol. 2002.
Abstract
CTLA-4 plays an important role in the down-regulation of activated T cells and in the establishment of peripheral tolerance. It has been hypothesized that CTLA-4 on the cell surface signals directly into T cells during primary immune responses, resulting in intrinsic T cell down-regulation. It is not known, however, whether CTLA-4 directly inhibits the less intense activating signals received by autoreactive T cells in the periphery. We investigated whether CTLA-4 acts intrinsically upon self-reactive cells in vivo, or whether it inhibits autoreactive cells indirectly, in a non-cell autonomous manner. The adoptive transfer of CTLA-4-deficient splenocytes or Thy 1(+) cells into recombinase-activating gene 2-deficient mice resulted in fatal inflammation and tissue destruction similar to that seen in CTLA-4-deficient mice. When an equivalent number of splenocytes or Thy 1(+) cells from wild-type animals was transferred with the CTLA-4-deficient cells, recipient mice survived indefinitely. Since CTLA-4 was absent in the T cells responsible for the inflammatory phenotype, the down-regulation of these autoreactive cells must have been facilitated indirectly by wild-type Thy 1(+) cells. In addition, a rapid reduction in the ratio of CTLA-4-deficient to wild-type cells was observed. We propose two possible indirect mechanisms by which CTLA-4 may function in the establishment and maintenance of peripheral tolerance.
Similar articles
- Lymphoproliferative disorder in CTLA-4 knockout mice is characterized by CD28-regulated activation of Th2 responses.
Khattri R, Auger JA, Griffin MD, Sharpe AH, Bluestone JA. Khattri R, et al. J Immunol. 1999 May 15;162(10):5784-91. J Immunol. 1999. PMID: 10229811 - Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4.
Tivol EA, Borriello F, Schweitzer AN, Lynch WP, Bluestone JA, Sharpe AH. Tivol EA, et al. Immunity. 1995 Nov;3(5):541-7. doi: 10.1016/1074-7613(95)90125-6. Immunity. 1995. PMID: 7584144 - CTLA4Ig prevents lymphoproliferation and fatal multiorgan tissue destruction in CTLA-4-deficient mice.
Tivol EA, Boyd SD, McKeon S, Borriello F, Nickerson P, Strom TB, Sharpe AH. Tivol EA, et al. J Immunol. 1997 Jun 1;158(11):5091-4. J Immunol. 1997. PMID: 9164923 - CTLA-4--the costimulatory molecule that doesn't: regulation of T-cell responses by inhibition.
Chambers CA, Allison JP. Chambers CA, et al. Cold Spring Harb Symp Quant Biol. 1999;64:303-12. doi: 10.1101/sqb.1999.64.303. Cold Spring Harb Symp Quant Biol. 1999. PMID: 11232300 Review. No abstract available. - CTLA-4, a negative regulator of T-lymphocyte activation.
Waterhouse P, Marengère LE, Mittrücker HW, Mak TW. Waterhouse P, et al. Immunol Rev. 1996 Oct;153:183-207. doi: 10.1111/j.1600-065x.1996.tb00925.x. Immunol Rev. 1996. PMID: 9010724 Review. No abstract available.
Cited by
- The emerging role of CTLA4 as a cell-extrinsic regulator of T cell responses.
Walker LS, Sansom DM. Walker LS, et al. Nat Rev Immunol. 2011 Nov 25;11(12):852-63. doi: 10.1038/nri3108. Nat Rev Immunol. 2011. PMID: 22116087 - On the Road to Immunotherapy-Prospects for Treating Head and Neck Cancers With Checkpoint Inhibitor Antibodies.
Ward FJ, Dahal LN, Abu-Eid R. Ward FJ, et al. Front Immunol. 2018 Sep 24;9:2182. doi: 10.3389/fimmu.2018.02182. eCollection 2018. Front Immunol. 2018. PMID: 30319637 Free PMC article. Review. - Modulation of CTLA-4 and GITR for cancer immunotherapy.
Avogadri F, Yuan J, Yang A, Schaer D, Wolchok JD. Avogadri F, et al. Curr Top Microbiol Immunol. 2011;344:211-44. doi: 10.1007/82_2010_49. Curr Top Microbiol Immunol. 2011. PMID: 20563707 Free PMC article. Review. - Infection of CD127+ (interleukin-7 receptor+) CD4+ cells and overexpression of CTLA-4 are linked to loss of antigen-specific CD4 T cells during primary human immunodeficiency virus type 1 infection.
Zaunders JJ, Ip S, Munier ML, Kaufmann DE, Suzuki K, Brereton C, Sasson SC, Seddiki N, Koelsch K, Landay A, Grey P, Finlayson R, Kaldor J, Rosenberg ES, Walker BD, Fazekas de St Groth B, Cooper DA, Kelleher AD. Zaunders JJ, et al. J Virol. 2006 Oct;80(20):10162-72. doi: 10.1128/JVI.00249-06. J Virol. 2006. PMID: 17005693 Free PMC article. - Anti-CTLA-4 antibody therapy: immune monitoring during clinical development of a novel immunotherapy.
Callahan MK, Wolchok JD, Allison JP. Callahan MK, et al. Semin Oncol. 2010 Oct;37(5):473-84. doi: 10.1053/j.seminoncol.2010.09.001. Semin Oncol. 2010. PMID: 21074063 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases